ES

Joan Salgado Gomez

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joan Salgado Gomez. Retrieved from https://idiyas.com/inventor/joan-salgado-gomez-ffxceytc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Joan Salgado Gomez: Innovator in Cardiovascular Disease Risk Assessment

Introduction

Joan Salgado Gomez is a prominent inventor based in Spain, recognized for her contributions to the field of cardiovascular disease risk assessment. With a focus on innovative methods for evaluating risk factors, she has made significant strides in improving health outcomes.

Latest Patents

Joan Salgado Gomez holds two notable patents related to cardiovascular disease. The first patent involves a method for reclassifying subjects to achieve a more accurate risk assessment using algorithms such as Framingham, Regicor, Score, Procamor, and Qrisk. This method combines the presence of various polymorphisms with conventional risk factors to determine the likelihood of developing cardiovascular disease. The second patent focuses on identifying risk markers for cardiovascular disease through the presence of different polymorphisms, along with kits designed for implementing this method.

Career Highlights

Joan is currently associated with Genincode Plc, where she applies her expertise in genetics and risk assessment. Her work aims to enhance the understanding of cardiovascular risks and improve patient care through innovative solutions.

Collaborations

Joan collaborates with esteemed colleagues, including Eduardo Salas Perez-Rasilla and Jaume Marrugat De La Iglesia, to further advance research in her field.

Conclusion

Joan Salgado Gomez is a trailblazer in the realm of cardiovascular disease risk assessment, with her innovative patents paving the way for improved health strategies. Her dedication to research and collaboration continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…